Trademark: 87508732
Word
ACEBIOS
Status
Dead
Status Code
710
Status Date
Friday, August 2, 2024
Serial Number
87508732
Registration Number
5385635
Registration Date
Tuesday, January 23, 2018
Mark Type
4
Filing Date
Wednesday, June 28, 2017
Published for Opposition
Tuesday, November 7, 2017
Cancellation Date
Friday, August 2, 2024

Trademark Owner History
ACEBIOS INCORPORATED - Original Registrant

Classifications
5 Acetaminophen; Antibiotic tablets; Antihistamines; Appetite suppressant pills; Cardiovascular treatment preparations; Cholesterol reducers; Cough treatment preparations; Dermatologicals; Diarrhea medication; Dietary supplements; Dietary supplements for controlling cholesterol; Dietary supplements for urinary health; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gastro-intestinal treatment preparations; Haemorrhoid preparations; Hemorrhoid preparations; Hormones; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Medicated dermatological preparations and substances; Natural herbal supplements; Natural supplements for treating candida; Natural supplements for treating depression and anxiety; Natural supplements for treating erectile dysfunction; Non-medicated topical gel for the prevention and treatment of cold and flu; Nutritional supplement for eliminating toxins from the body; Paracetamol; Penicillin preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Preparation for the relief of pain; Preparations for the treatment of asthma; Preparations for the treatment of burns; Preparations for treating colds; Vaginal preparations, namely, antifungals; Vitamin preparations

Trademark Events
Nov 7, 2017
Published For Opposition
Jan 23, 2018
Registered-Principal Register
Apr 2, 2018
Teas Change Of Owner Address Received
Jul 1, 2017
New Application Entered
Jul 6, 2017
New Application Office Supplied Data Entered
Sep 26, 2017
Assigned To Examiner
Sep 27, 2017
Approved For Pub - Principal Register
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 2, 2024
Cancelled Sec. 8 (6-Yr)
Apr 2, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered

Trademark Alertz updated from USPTO on 2030-01-24